45.26 USD
↗ 0.49 (1.09%)AT CLOSE (03:59 PM EDT)
Prestige Consumer Healthcare Inc.
PBHNYSE • USD
45.54
↗ 0.28 (0.62%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
45.54
↗ 0.28 (0.62%)
Market: CLOSED
Prestige Consumer Healthcare Inc. (PBH) trades at $45.26 per share. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, PBH appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Oct 2, 2026.
Open?$44.88
High?$45.75
Low?$44.60
Prev. Close?$44.77
Volume?543.9K
Avg. Volume?562.3K
VWAP?$45.35
Rel. Volume?0.97x
Bid / Ask
Bid?$43.50 × 100
Ask?$49.92 × 100
Spread?$6.42
Midpoint?$46.71
Valuation & Ratios
Market Cap?2.1B
Shares Out?47.4M
Float?46.6M
Float %?98.5%
P/E Ratio?12.47
P/B Ratio?1.12
EPS?$3.63
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
Employees
890
Market Cap
2.1B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2005-02-10
Address
660 WHITE PLAINS RD.
TARRYTOWN, NY 10591
Phone: (914) 524-6800
TARRYTOWN, NY 10591
Phone: (914) 524-6800
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?22
Momentum?35
Short Sent.?54
Piotroski F-Score?3/9Weak
Altman Z-Score?1.57Distress
Confidence?74%Moderate
Short InterestHigh
Short % of Float?10.28%High
Short Interest?4.8M
Days to Cover?9.5
Free Float46.6M
Avg Daily Volume507.5K
Settlement Date2026-09-15
Financial Health
Current Ratio?3.23Strong
Quick Ratio?1.99Adequate
Cash Ratio?0.58Adequate
Debt/Equity?1.06Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score89/100
P/E?12.5CHEAP▾
Peers100
S&P90
P/B?1.12CHEAP▾
Peers100
S&P94
P/S?1.94CHEAP▾
Peers100
S&P68
P/FCF?9.1CHEAP▾
Peers100
S&P91
EV/EBITDA?12.7FAIR▾
Peers100
S&P64
EV/Sales?3.70FAIR▾
Peers100
S&P51
Returns & Efficiency
ROE?9.0%FAIR▾
Peers50
S&P30
ROA?3.8%FAIR▾
Peers50
S&P34
Cash Flow & Enterprise
FCF?$235.4M
Enterprise Value?$4.1B
Fundamentals ratios updated end of day